Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1741519

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1741519

Hyperthermia Cancer Treatment Market, By Treatment Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Hyperthermia Cancer Treatment Market is estimated to be valued at USD 210.5 Mn in 2025 and is expected to reach USD 318.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 210.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.10% 2032 Value Projection: USD 318.6 Mn

Hyperthermia cancer treatment is a novel therapeutic approach that utilizes heat to treat cancer cells. It involves raising the temperature of cancerous cells, either from external sources or by directing heat specifically to the tumor site. Hyperthermia can be used in conjunction with other cancer treatments like chemotherapy and radiation therapy to improve their efficacy.

By subjecting malignant cells to higher temperatures, hyperthermia treatment aims to kill cancer cells, enhance the effectiveness of radiation therapy, and increase the uptake of chemotherapeutic agents. It is a non-invasive method that is gaining momentum in the field of oncology due to its potential to improve patient outcomes and minimize side effects compared to traditional treatments.

Market Dynamics:

The global hyperthermia cancer treatment market is expected to experience significant growth during the forecast period. The market dynamics driving this growth include various factors such as the rising prevalence of cancer worldwide, increasing adoption of innovative cancer treatment methods, and advancements in technology.

Rising cases of cancer globally is one of the key drivers of the Hyperthermia cancer treatment market. According to the data published by the International Agency for Research on Cancer in May 2021, an estimated 19.3 million new cancer cases occurred in 2020. This growing incidence of cancer is expected to fuel demand for effective treatment options, including hyperthermia therapy.

Moreover, technological advancements in hyperthermia treatment devices are expected to propel market growth. The development of advanced heating techniques, such as regional and whole-body hyperthermia, has improved treatment outcomes and expanded the applicability of hyperthermia therapy. Additionally, the integration of hyperthermia devices with imaging modalities allows for real-time temperature monitoring and precise targeting of tumor cells, further enhancing treatment efficacy.

While the market holds immense potential, certain factors may restrain its growth. Limited awareness about hyperthermia treatment among healthcare professionals and patients, high treatment costs, and reimbursement challenges are some of the obstacles that may hinder market expansion. However, efforts to increase awareness, favorable reimbursement policies, and ongoing research and development activities are expected to overcome these challenges.

Key Features of the Study:

  • This report provides in-depth analysis of the global hyperthermia cancer treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR, %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include MagForce AG, Andromedic S.r.l., Celsius42 GmbH, Oncotherm Kft, Pyrexar Medical, YAMAMOTO VINITA CO.,LTD, Nanoprobes, Alba Hyperthermia System, Novavida, and Sensius.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgradation, market expansion, and marketing tactics.
  • The global hyperthermia cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hyperthermia cancer treatment market

Hyperthermia Cancer Treatment Market Detailed Segmentation:

  • By Treatment Type:
    • Local Hyperthermia
    • Regional Hyperthermia
    • Whole Body Hyperthermia
  • By Application:
    • Prostate Cancer
    • Breast Cancer
    • Cervical Cancer
    • Skin Cancer
    • Other Cancers
  • By End User:
    • Hospitals
    • Clinic
    • Specialty Centres
    • Others (Academic and Research Institute)
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • MagForce AG
    • Andromedic S.r.l.
    • Celsius42 GmbH
    • Oncotherm Kft
    • Pyrexar Medical
    • YAMAMOTO VINITA CO.,LTD
    • Nanoprobes
    • Alba Hyperthermia System
    • Novavida
    • Sensius
Product Code: CMI6415

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hyperthermia Cancer Treatment Market, By Treatment Type
    • Global Hyperthermia Cancer Treatment Market, By Application
    • Global Hyperthermia Cancer Treatment Market, By End User
    • Global Hyperthermia Cancer Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of cancer worldwide
    • Restraints
  • High costs of hyperthermia systems
    • Opportunities
  • Growing popularity of nanoparticle-mediated hyperthermia
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hyperthermia Cancer Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Hyperthermia Cancer Treatment Market , By Treatment Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Local Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Regional Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Whole Body Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Hyperthermia Cancer Treatment Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Hyperthermia Cancer Treatment Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Clinic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Academic and Research Institute)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Hyperthermia Cancer Treatment Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • MagForce AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Andromedic S.r.l.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsius42 GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Oncotherm Kft
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pyrexar Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • YAMAMOTO VINITA CO.,LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nanoprobes
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alba Hyperthermia System
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novavida
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sensius
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!